"We were pleased that blinded data from the ongoing Phase 2 trial of BRTX-100 in cLDD continues to be in-line to meet the primary safety endpoint of study, and that the positive preliminary efficacy ...

BioRestorative Therapies, Inc. ("BioRestorative", "BRTX" or the "Company") (NASDAQ:BRTX), a clinical stage regenerative medicine innovator focused on ...

Hidden fat stored deep within muscles can significantly raise your risk of heart disease, heart attacks, and heart failure, ...

A large cross-sectional study using NHANES data found a non-linear negative relationship between lipid accumulation product ...